Aeglea Biotherapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $81M | 1.6M | 50.45 |
| 2025-12-31 | $53M | 1.6M | 32.76 |
| 2025-09-30 | $10M | 621k | 16.76 |
| 2025-06-30 | $14M | 931k | 14.97 |
| 2025-03-31 | $4.0M | 249k | 16.14 |
| 2024-12-31 | $12M | 507k | 23.28 |
| 2024-09-30 | $13M | 429k | 29.41 |
| 2024-06-30 | $7.3M | 308k | 23.55 |
| 2024-03-31 | $3.0M | 79k | 37.94 |